AbbVie Inc (ABBV)
Working capital turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 54,318,000 | 58,054,000 | 56,197,000 | 45,804,000 | 33,266,000 |
| Total current assets | US$ in thousands | 33,002,000 | 28,463,000 | 27,928,000 | 24,173,000 | 49,519,000 |
| Total current liabilities | US$ in thousands | 37,841,000 | 29,538,000 | 35,194,000 | 28,661,000 | 15,585,000 |
| Working capital turnover | — | — | — | — | 0.98 |
December 31, 2023 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $54,318,000K ÷ ($33,002,000K – $37,841,000K)
= —
The working capital turnover ratio for Abbvie Inc for the years 2019 to 2023 is as follows:
- Dec 31, 2019: 0.98
- Dec 31, 2020: Not Available
- Dec 31, 2021: Not Available
- Dec 31, 2022: Not Available
- Dec 31, 2023: Not Available
The working capital turnover ratio measures how efficiently a company is using its working capital to generate revenue. A higher ratio indicates that the company is effectively utilizing its working capital to support sales activities.
Based on the data provided, we only have the working capital turnover ratio for 2019, which was 0.98. Without the figures for the subsequent years, it is challenging to track the trend of the working capital turnover ratio for Abbvie Inc over time.
A consistent analysis of the working capital turnover ratio for multiple years could provide valuable insights into the company's operational efficiency and financial management. It would be beneficial to have more recent data to assess whether there have been any improvements or fluctuations in Abbvie Inc's working capital turnover performance.
Peer comparison
Dec 31, 2023